PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.34
+0.53%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.34
From 52W high−71.97%
Volume25790.00
Market cap$3.67M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.34
From 52W high
−71.97%
Volume
25790.00
Market cap
$3.67M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.6x
P/E (TTM)
—
RSI (14)
36.3
MomentumView details →
1D Return
+0.53%
YTD Return
−50.91%
SummaryUpdated Jul 1, 2026
PharmaCyte Biotech, Inc. (OTCQB:PMCB) is a biotechnology company founded in 1996 and headquartered in Las Vegas, Nevada. Originally incorporated as Nuvilex, Inc., the company changed its name to PharmaCyte Biotech in January 2015 and went public in 2013. The company is a clinical-stage biotechnology firm focused on developing innovative cellular therapies for treating cancer, diabetes, and malignant ascites using its proprietary encapsulation technology platform.
Similar companies
Latest newsMore news →